These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of destruction of midbrain raphe nuclei on the behavioral effects of dopaminergic substances and I-tryptophan]. Allikmets LKh, Zharkovskiĭ AM, Arro AG. Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(5):1030-5. PubMed ID: 563144 [Abstract] [Full Text] [Related]
3. [Analysis of apomorphine aggessiveness and stereotypy: role of serotonin- and cholinergic systems of the brain]. Zharkovskiĭ AM, Allikmets KKh. Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(6):1303-7. PubMed ID: 145765 [Abstract] [Full Text] [Related]
4. Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems. Allikmets LH, Zharkovsky AM. Ann Ist Super Sanita; 1978; 14(1):63-70. PubMed ID: 40501 [Abstract] [Full Text] [Related]
5. [The influence of 1-DOPA on emotional responses and serotonin metabolism in the rat brain]. Allikmets LKh, Zharkovskiĭ AM. Biull Eksp Biol Med; 1976 Feb; 81(2):134-7. PubMed ID: 1084170 [Abstract] [Full Text] [Related]
6. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats. Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD. Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859 [Abstract] [Full Text] [Related]
7. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system. Kania BF. Acta Physiol Pol; 1979 May; 30(2):279-87. PubMed ID: 572616 [Abstract] [Full Text] [Related]
8. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice. Thornburg JE, Moore KE. J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250 [Abstract] [Full Text] [Related]
9. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123]. Guzevatykh LS, Ostrovskaia RU, Gudasheva TA, Zaĭtseva NI, Voronina TA. Eksp Klin Farmakol; 2002 Jan; 65(1):3-6. PubMed ID: 12025780 [Abstract] [Full Text] [Related]
12. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy. Markovska V, Georgiev V. Acta Physiol Pharmacol Bulg; 1982 Jan; 8(3):67-73. PubMed ID: 6820612 [Abstract] [Full Text] [Related]
13. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease. Mandel RJ. Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287 [Abstract] [Full Text] [Related]
14. Apomorphine and piribedil in rats: biochemical and pharmacologic studies. Butterworth RF, Poignant JC, Barbeau A. Adv Neurol; 1975 Jan; 9():307-26. PubMed ID: 1170716 [Abstract] [Full Text] [Related]
15. [Sensitization of male rats to aggressive behavior by apomorphine]. Allikmets LKh, Vasar EE. Zh Vyssh Nerv Deiat Im I P Pavlova; 1982 Jan; 32(1):130-5. PubMed ID: 7199793 [Abstract] [Full Text] [Related]
16. Dopamine receptor changes in response to prolonged treatment with L-dopa. Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M. J Neural Transm Suppl; 1986 Jan; 22():33-45. PubMed ID: 2946813 [Abstract] [Full Text] [Related]
17. [The role of the dopamine and noradrenaline systems in regulating autogenic motor activity in rat pups]. Timofeeva OP. Zh Evol Biokhim Fiziol; 1989 Jan; 25(1):123-5. PubMed ID: 2728686 [Abstract] [Full Text] [Related]
18. The involvement of serotonin in the mechanism of central action of apomorphine. Grabowska M. Pol J Pharmacol Pharm; 1976 Jan; 28(4):389-94. PubMed ID: 790347 [Abstract] [Full Text] [Related]
19. Behavioral effects of apomorphine during development of rats. Brus R, Herman ZS, Jamrozik Z. Acta Physiol Pol; 1977 Jan; 28(3):243-6. PubMed ID: 561515 [Abstract] [Full Text] [Related]
20. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs. Kenny M, Leonard BE. J Neurosci Res; 1980 Jan; 5(4):291-8. PubMed ID: 6107385 [Abstract] [Full Text] [Related] Page: [Next] [New Search]